Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. AMD
6. GOOG
7. INTC
8. CSX
9. KNX
10. IBM

Go back to Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis
Enliven Marketing Technologies Corporation (NASDAQ: ENLV) Delayed: 4.36 -0.23 (5.01%)
Previous Close $4.59    52 Week High $0.94 
Open $4.52    52 Week Low $0.47 
Day High $4.61    P/E N/A 
Day Low $4.30    EPS $-0.11 
Volume 130,574       

Enliven Marketing Technologies Corporation (NASDAQ: ENLV) Delayed: 4.36 -0.23 (5.01%)
Previous Close $4.59    52 Week High $0.94 
Open $4.52    52 Week Low $0.47 
Day High $4.61    P/E N/A 
Day Low $4.30    EPS $-0.11 
Volume 130,574